NCT07775404: A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
- State
- Under way
- Phase
- Phase 3
- People
- 351 planned
- Started
- 21 Aug 2026
- Primary completion
- 6 Apr 2028
- Arms
- Arm 1 - Dose 1, Arm 2 - Dose 2
- Results
- None posted
- 20 Aug 2026: Trial registered
- 21 Aug 2026: Trial started